logo

For the Inventor, By the Inventor

Molndal, Sweden

Lanna Li

This inventor holds 16 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignee: Astrazeneca Ab. Active years: 2003-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lanna Li. Retrieved from https://idiyas.com/inventor/lanna-li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 12.5

 

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 29(Granted Patents)


Location History:

  • Göteborg, SE (2003)
  • Goteborg, SE (2009)
  • Molndal, SE (2007 - 2012)
  • Mölndal, SE (2003 - 2013)

Company Filing History:

goldMedal16 out of 1,534 
 
Astrazeneca Ab
 patents

Years Active: 2003-2013

Loading Chart...
Loading Chart...
Areas of Expertise:
Azetidin Compounds
Isothiazol Derivatives
Liver X Receptor
PPAR Modulators
Benzoic Acid Derivatives
Phenylpropionic Acids
Insulin Resistance
Guanidine Derivatives
Phenylalkyloxy Compounds
Therapeutic Agents
3-Aryl Propionic Acids
16 patents (USPTO):Explore Patents
1. 8546375 - (3-(4-(aminomethyl)phenoxy or phenylthio)azetidin-1-yl)(5-phenyl-1,3,4-oxadiazol-2-yl)methanone compounds (2013-10-01),
2. 8110566 - Therapeutic agents 713 (2012-02-07),
3. 7960380 - Non-anilinic derivatives of isothiazol-3(2H)-one 1,1-dioxides as liver X receptor modulators (2011-06-14),
4. 7723333 - Non-anilinic derivatives of isothiazol-3(2H)-one 1,1-dioxides as liver X receptor modulators (2010-05-25),
5. 7582629 - [object Object] (2009-09-01),
6. 7521461 - Benzoic acid derivatives as modulators of PPAR alpha and gamma (2009-04-21),
7. 7514471 - Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor α (PPAR) (2009-04-07),
8. 7488844 - Therapeutic agents (2009-02-10),
9. 7462644 - Therapeutic agents (2008-12-09),
10. 7355069 - Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance (2008-04-08),
11. 7351858 - Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance (2008-04-01),
12. 7256307 - Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor α(PPAR) (2007-08-14),
13. 7241923 - Phenylalkyloxy-phenyl derivatives (2007-07-10),
14. 7169810 - Guanidine and amidine acid derivatives and analogs and methods of using the same (2007-01-30),
15. 6630600 - 3-aryl propionic acid derivatives and analogs (2003-10-07),

Title: Lanna Li: A Pioneer in Inventions

Introduction:

Lanna Li, a visionary inventor based in Mölndal, Sweden, has dedicated his career to pushing the boundaries of innovation and creating a better future through his groundbreaking inventions. With a relentless drive and passion for exploring what is possible, Lanna Li has established himself as a true pioneer in the world of inventions.

Latest Patents:

Lanna Li's latest patents showcase his expertise in the field of pharmaceuticals and treatment methods for melanin-concentrating hormone related diseases. His patents include compounds such as (3-(4-(aminomethyl)phenoxy or phenylthio)azetidin-1-yl)(5-phenyl-1,3,4-oxadiazol-2-yl)methanone compounds and therapeutic agents 713. These inventions highlight his commitment to developing innovative solutions for complex medical conditions.

Career Highlights:

With an impressive portfolio of 16 patents, Lanna Li has made significant contributions to the field of pharmaceuticals and drug development. His work at Astrazeneca Ab, a renowned pharmaceutical company, has been instrumental in advancing the industry's understanding of melanin-concentrating hormone related diseases. Lanna Li's innovative approach and dedication to his craft have earned him recognition as a leading figure in the field of inventions.

Collaborations:

Throughout his career, Lanna Li has collaborated with esteemed colleagues such as Robert Andrew Judkins and Eva-Lotte Lindstedt Alstermark. Together, they have worked on various projects aimed at developing novel pharmaceutical compounds and treatment strategies. These collaborations have enabled Lanna Li to exchange ideas, share expertise, and collectively drive innovation in the field of inventions.

Conclusion:

In conclusion, Lanna Li's unwavering commitment to innovation, coupled with his remarkable achievements in the field of inventions, solidifies his legacy as a true pioneer. His contributions to the development of pharmaceutical compounds and treatment methods have not only advanced the industry but also paved the way for a brighter future in healthcare. Lanna Li's passion for pushing boundaries and creating positive change through his inventions sets him apart as a visionary inventor of our time.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…